India Antibiotic Guideline for Skin and Soft Tissue Infections

Published On 2017-02-03 08:05 GMT   |   Update On 2017-02-03 08:05 GMT

In 2016 National Centre For Disease, Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India came out with National Treatment Guidelines for Antimicrobial Use in Infectious Diseases.



Following are major recommendation for Skin & Soft Tissue Infections:

































ConditionLikely Causative OrganismsEmpiric antibiotics (presumptive antibiotics)Alternative antibioticsComments
CellulitisStreptococcus pyogenes(common), S.aureusAmoxicillinClavulanate 1.2gm IV TDS/625 mg oral TDS

or

Ceftriaxone 2gm IV OD
Clindamycin 600-900mg IV TDSTreat for 5-7 days.
FurunculosisS.aureusAmoxicillinClavulanate 1.2gm IV/Oral 625 TDS

or

Ceftriaxone 2gm IV OD Duration – 5-7 days
Clindamycin 600-900mg IV TDSGet pus cultures before starting antibiotics
Necrotizing fasciitisStreptococcus pyogenes, S. aureus, anaerobes, Enterobacteriaceae (polymicrobial)PiperacillinTazobactam 4.5gm IV 6hourly

or CefoperazoneSulbactam 3gm IV 12hourly

AND

Clindamycin 600-900mg IV 8 hourly Duration depends on the progress
Imipenem 1g IV8hourly

or

Meropenem 1gm IV 8hourly

AND

Clindamycin 600-900mg IV TDS/linezolid 600 mg IV BD/daptomycin 6mg/kg/day
Early surgical intervention crucial

You can read the full Guideline by clicking on the following link :


http://www.ncdc.gov.in/writereaddata/linkimages/AMR_guideline7001495889.pdf

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News